Literature DB >> 15170031

Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice?

A Bourdin1, I Serre, H Flamme, P Vic, D Neveu, P Aubas, P Godard, P Chanez.   

Abstract

BACKGROUND: International guidelines stress the importance of accurately discriminating between asthma and chronic obstructive pulmonary disease (COPD). Although characteristic pathological features have been described for both conditions, their discriminatory power has never been systematically assessed.
METHODS: Endobronchial biopsy (EBB) specimens from patients with a clear clinical diagnosis of asthma and COPD (50 per group) were examined by three pathologists in a double blind manner. They were asked to propose a pathological diagnosis of either asthma or COPD and to analyse qualitatively the most frequent abnormalities reported in the literature.
RESULTS: The sensitivity and specificity of EBB ranged from 36% to 48% and from 56% to 79%, respectively. Eosinophils strongly biased the pathological diagnoses in favour of asthma, whereas their estimated prevalence was similar (11-37% in asthma and 13-41% in COPD). Metaplasia (11-39% in COPD, 1-18% in asthma) and epithelial inflammation (28-61% in COPD, 11-38% in asthma) tended to be specific to COPD, whereas epithelial desquamation (80-98% in asthma, 61-88% in COPD) and basement membrane thickening (71-94% in asthma, 53-88% in COPD) tended to be associated with asthma. There was acceptable intra- and inter-observer agreement only for metaplasia and epithelial eosinophils.
CONCLUSIONS: Specific histopathological features of asthma and COPD probably exist, but current routine analysis procedures to assess EBB specimens are not sufficiently discriminatory. This might be rectified by improving pathological definitions.

Entities:  

Mesh:

Year:  2004        PMID: 15170031      PMCID: PMC1747055          DOI: 10.1136/thx.2003.016899

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

Review 1.  Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment.

Authors:  Peter Jeffery; Stephen Holgate; Sally Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2003-09-15       Impact factor: 21.405

2.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.

Authors:  M Saetta; A Di Stefano; G Turato; F M Facchini; L Corbino; C E Mapp; P Maestrelli; A Ciaccia; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

3.  Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma.

Authors:  J K Sont; L N Willems; C E Evertse; R Hooijer; P J Sterk; J H van Krieken
Journal:  Eur Respir J       Date:  1997-11       Impact factor: 16.671

Review 4.  Assessment of airway inflammation in asthma.

Authors:  A M Vignola; J Bousquet; P Chanez; R Gagliardo; A M Merendino; G Chiappara; G Bonsignore
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

5.  Some histological changes in chronic bronchitis and asthma.

Authors:  G Salvato
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

Review 6.  Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

Authors:  P J Sterk; L M Fabbri; P H Quanjer; D W Cockcroft; P M O'Byrne; S D Anderson; E F Juniper; J L Malo
Journal:  Eur Respir J Suppl       Date:  1993-03

7.  Clinical biostatistics. LIV. The biostatistics of concordance.

Authors:  M S Kramer; A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

8.  Measuring the reliability of clinical data: the case for using three observers.

Authors:  S D Walter
Journal:  Rev Epidemiol Sante Publique       Date:  1984       Impact factor: 1.019

9.  Corticosteroid reversibility in COPD is related to features of asthma.

Authors:  P Chanez; A M Vignola; T O'Shaugnessy; I Enander; D Li; P K Jeffery; J Bousquet
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

10.  Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease.

Authors:  J Y Lacoste; J Bousquet; P Chanez; T Van Vyve; J Simony-Lafontaine; N Lequeu; P Vic; I Enander; P Godard; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1993-10       Impact factor: 10.793

View more
  12 in total

Review 1.  A challenge to the seven widely believed concepts of COPD.

Authors:  Feisal A Al-Kassimi; Esam H Alhamad
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-14

2.  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.

Authors:  Xaver Baur; Prudence Bakehe; Henning Vellguth
Journal:  J Occup Med Toxicol       Date:  2012-09-26       Impact factor: 2.646

3.  Overlap Between Asthma and COPD: Where the Two Diseases Converge.

Authors:  So Ri Kim; Yang Keun Rhee
Journal:  Allergy Asthma Immunol Res       Date:  2010-09-13       Impact factor: 5.764

4.  The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly.

Authors:  Amir A Zeki; Michael Schivo; Andrew Chan; Timothy E Albertson; Samuel Louie
Journal:  J Allergy (Cairo)       Date:  2011-10-30

5.  The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function.

Authors:  Jianmin Jin; Xiaofang Liu; Yongchang Sun
Journal:  Respir Res       Date:  2014-10-29

6.  Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome.

Authors:  Yuanyuan Guo; Chunlin Hong; Yanhong Liu; Huinuan Chen; Xiaohua Huang; Minli Hong
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

7.  Endobronchial biopsy in the final diagnosis of chronic obstructive pulmonary disease and asthma: a clinicopathological study.

Authors:  Maria Abdulrahim Arafah; Emad Raddaoui; Faisal Al Kassimi; Esam H Alhamad; Ahmed Amer Alboukai; Ahlam Abdullah Alshedoukhy; Abderrahman Ouban
Journal:  Ann Saudi Med       Date:  2018 Mar-Apr       Impact factor: 1.526

8.  Reticular basement membrane in asthma and COPD: similar thickness, yet different composition.

Authors:  Jeroen J W Liesker; Nick H Ten Hacken; Mieke Zeinstra-Smith; Steven R Rutgers; Dirkje S Postma; Wim Timens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

9.  Abrupt withdrawal of inhaled corticosteroids does not result in spirometric deterioration in chronic obstructive pulmonary disease: Effect of phenotyping?

Authors:  Feisal A Al-Kassimi; Esam H Alhamad; Mohammed S Al-Hajjaj; Abdullah A Abba; Emad Raddaoui; Shaffi A Shaikh
Journal:  Ann Thorac Med       Date:  2012-10       Impact factor: 2.219

10.  Old dilemma: asthma with irreversible airway obstruction or COPD.

Authors:  Fatemeh Fattahi; Judith M Vonk; Nicole Bulkmans; Ruth Fleischeuer; Annette Gouw; Katrien Grünberg; Thais Mauad; Helmut Popper; Aloisio Felipe-Silva; Bart Vrugt; Joanne L Wright; Hui-Min Yang; Janwillem W H Kocks; Machteld N Hylkema; Dirkje S Postma; Wim Timens; Nick H T Ten Hacken
Journal:  Virchows Arch       Date:  2015-09-14       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.